Young Adult Pharmacokinetics

Young adult pharmacokinetics describes stable pharmacokinetic parameters in 18-40 year populations serving as reference baseline. Renal and hepatic function achieve adult levels. Metabolic enzyme expression stabilises. Distribution volumes approach adult values. Age-related changes minimal compared to extremes.

Regulatory submissions reference young adult pharmacokinetics. Clinical trials enroll diverse ages assessing variation. Dose adjustments account for age-related changes. Population pharmacokinetics characterise age effects. Post-approval monitoring identifies age-specific patterns.